Primary Sclerosing Cholangitis (PSC) Clinical Trial
Official title:
A Pilot, Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of LUM001, an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTi), in Patients With Primary Sclerosing Cholangitis
The study is an open-label study in adults with primary sclerosing cholangitis to evaluate the safety, tolerability, and effect of 14-weeks of daily dosing of LUM001.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05082779 -
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159
|
Phase 1 | |
| Completed |
NCT06037577 -
Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT01672853 -
Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)
|
Phase 2 | |
| Completed |
NCT01819766 -
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
|
N/A | |
| Active, not recruiting |
NCT01161992 -
Genomics of Primary Sclerosing Cholangitis (PSC)
|
||
| Completed |
NCT02808312 -
Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function
|
Phase 1 | |
| Completed |
NCT03333928 -
A POC and Dose-Ranging Study of HTD1801 in PSC Patients
|
Phase 2 | |
| Completed |
NCT02177136 -
Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
|
Phase 2 | |
| Completed |
NCT03766035 -
Cholangioscopy in Primary Sclerosing Cholangitis (PSC)
|
||
| Completed |
NCT01695174 -
A Pilot Study of Xifaxan to Treat Patients With PSC
|
Phase 1 | |
| Recruiting |
NCT06026865 -
S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)
|
N/A |